<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7441776\results\search\disease\results.xml">
  <result pre="JahidulaSumanRasel HosenaBiswasSouravaRahatEmon UddinaHossenMd. RubelaIslamRajibaHossainMd NayeemaMamunAbdulla AlbKhanMaksudaAliMd Ackasahttps://orcid.org/0000-0002-1698-7044HalimMohammad A.ac[a], Division of" exact="Infectious" post="Diseases and Division of Computer-Aided Drug Design, The Red-Green"/>
  <result pre="HosenaBiswasSouravaRahatEmon UddinaHossenMd. RubelaIslamRajibaHossainMd NayeemaMamunAbdulla AlbKhanMaksudaAliMd Ackasahttps://orcid.org/0000-0002-1698-7044HalimMohammad A.ac[a], Division of Infectious" exact="Diseases" post="and Division of Computer-Aided Drug Design, The Red-Green Research"/>
  <result pre="complexes. MD simulations are applied for the most promising drugs." exact="Structural" post="stability and compactness are observed for the drugâ€&quot;Mpro complexes."/>
  <result pre="was identified in Wuhan, China in December 2019 spreading an" exact="infectious" post="pneumonia-like disease (Huang etÂ al., 2020). The International Committee"/>
  <result pre="in Wuhan, China in December 2019 spreading an infectious pneumonia-like" exact="disease" post="(Huang etÂ al., 2020). The International Committee on Taxonomy"/>
  <result pre="al., 2020). The World Health Organization (WHO) officially named the" exact="disease" post="caused by SARS-CoV-2 as Coronavirus disease (COVID-19) on 11"/>
  <result pre="(WHO) officially named the disease caused by SARS-CoV-2 as Coronavirus" exact="disease" post="(COVID-19) on 11 February 2020. On the basis of"/>
  <result pre="as a pandemic (Bedford etÂ al., 2020). To date, the" exact="total" post="numbers of reported cases have reached over 5 million"/>
  <result pre="more than 300 thousand (Worldometer, 2020). Earlier, epidemics of severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) in Guangdong, China in 2003"/>
  <result pre="than 300 thousand (Worldometer, 2020). Earlier, epidemics of severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) in Guangdong, China in 2003 and"/>
  <result pre="300 thousand (Worldometer, 2020). Earlier, epidemics of severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) in Guangdong, China in 2003 and Middle"/>
  <result pre="coronavirus (SARS-CoV) in Guangdong, China in 2003 and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in 2012 have shown a high"/>
  <result pre="(SARS-CoV) in Guangdong, China in 2003 and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in 2012 have shown a high fatality"/>
  <result pre="is closely related to (with 88% identity) two bat-derived severe" exact="acute" post="respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL- CoVZXC21, collected"/>
  <result pre="closely related to (with 88% identity) two bat-derived severe acute" exact="respiratory" post="syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL- CoVZXC21, collected in"/>
  <result pre="related to (with 88% identity) two bat-derived severe acute respiratory" exact="syndrome" post="(SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL- CoVZXC21, collected in 2018"/>
  <result pre="continuous and discontinuous RNA synthesis that is mediated by the" exact="viral" post="replicate (Sola etÂ al., 2015). The main protease (Mpro)"/>
  <result pre="2020). Thus, the main protease plays a vital role in" exact="viral" post="replication. The main protease (also known as 3C-like protease)"/>
  <result pre="(3CL-Pro) of SARS-CoV-2 was identified and repositioned at the RCSB" exact="Protein" post="Data bank (PDB) (Jin etÂ al., 2020). The crystallized"/>
  <result pre="of SARS-CoV-2 main protease (Mpro,3CLpro) was collected from the RCSB" exact="Protein" post="Data Bank (PDB) database (PDB-ID:6LU7, Resolution = 2.16â€‰Ã…, Method:"/>
  <result pre="Vina was used for virtual screening (Dallakyan &amp;amp; Olson, 2015)." exact="Structural" post="optimization of the drugs was carried out with universal"/>
  <result pre="force field (UFF) using the steepest descent optimization algorithm, a" exact="total" post="of 2000 minimization steps (Ahmed etÂ al., 2020). These"/>
  <result pre="Ewald method was used for calculating long-range electrostatic interactions. A" exact="periodic" post="boundary condition was utilized to carry out the simulation."/>
  <result pre="simulated annealing method, using the steepest gradient approach (5000 cycles)." exact="Normal" post="simulation speed (1.25 fs time step) was maintained during"/>
  <result pre="areas. Figure 4. Analysis of RMSD, RMSF, SASA, Rg and" exact="total" post="number of hydrogen bonds of apoâ€&quot;Mpro and selected four"/>
  <result pre="(d) Radius of gyration (Rg) over the entire simulation, (e)" exact="Total" post="H-bond count throughout the simulation and (f) Binding Free"/>
  <result pre="the folding or conformational changes of protein structure, while a" exact="lower" post="degree of fluctuation over the simulation period indicates rigidity"/>
  <result pre="trend until 40â€‰ns of MD trajectory. Simeprevirâ€&quot;Mpro and Ergotamineâ€&quot;Mpro showed" exact="lower" post="SASA value than the control drugâ€&quot;Mpro complexes. The overall"/>
  <result pre="bonds and binding free energy of the selected drugsâ€&quot;Mpro complexes." exact="Complex" post="RMSD (Ã…) SASA (Ã…2) Radius of gyration (Ã…) Number"/>
  <result pre="significant contribution to the conformational stability of the complex, the" exact="total" post="number of hydrogen bonds is calculated (Figure 4(e)). The"/>
  <result pre="for analysis. The first two PCs explained 91.74% of the" exact="total" post="variance, where PC1 contributed 75.07% and PC2 contributed 16.67%"/>
  <result pre="3D-QSAR studies on maslinic acid analogs for anticancer activity against" exact="breast cancer" post="cell line. Scientific Reports, (1), 1310.1038/s41598-017-06131-028144038 BakerN. A., SeptD.,"/>
  <result pre="studies on maslinic acid analogs for anticancer activity against breast" exact="cancer" post="cell line. Scientific Reports, (1), 1310.1038/s41598-017-06131-028144038 BakerN. A., SeptD.,"/>
  <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting Wuhan. Emerging Microbes &amp;amp; Infections, (1), 221â€&quot;236."/>
  <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerging Microbes &amp;amp; Infections, (1), 221â€&quot;236."/>
  <result pre="a tool to discover new Î²-haematin inhibitors with activity against" exact="malaria" post="parasites. Scientific Reports, (1), 337410.1038/s41598-020-60221-032099045 DicksonC. J., MadejB. D.,"/>
  <result pre="Gaussian 09, A.02. Gaussian, Inc. Funar-TimofeiS., BorotaA., &amp;amp; CrisanL. (2017)." exact="Combined" post="molecular docking and QSAR study of fused heterocyclic herbicide"/>
  <result pre="M., SamborskiyD. V., SidorovI., SolaI., &amp;amp; ZiebuhrJ. (2020). The species" exact="Severe" post="acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it"/>
  <result pre="SamborskiyD. V., SidorovI., SolaI., &amp;amp; ZiebuhrJ. (2020). The species Severe" exact="acute" post="respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2."/>
  <result pre="V., SidorovI., SolaI., &amp;amp; ZiebuhrJ. (2020). The species Severe acute" exact="respiratory" post="syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature"/>
  <result pre="technology (Vol. 20). Wiley. 10.1016/S0922-3487(98)80046-4 MassovaI., &amp;amp; KollmanP. A. (2000)." exact="Combined" post="molecular mechanical and continuum solvent approach (MM- PBSA/GBSA) to"/>
 </snippets>
</snippetsTree>
